Table of Content
"1 INTRODUCTION 49
1.1 STUDY OBJECTIVES 49
1.2 MARKET DEFINITION 49
1.3 STUDY SCOPE 51
1.3.1 MARKETS COVERED – BY TYPE 51
1.3.2 MARKETS COVERED – BY REGION 52
1.3.3 YEARS CONSIDERED 52
1.4 CURRENCY 53
TABLE 1 STANDARD CURRENCY CONVERSION RATES 53
1.5 LIMITATIONS 53
1.6 STAKEHOLDERS 53
1.7 SUMMARY OF CHANGES 54
2 RESEARCH METHODOLOGY 55
2.1 RESEARCH DATA 55
FIGURE 1 RESEARCH DESIGN 55
2.1.1 SECONDARY DATA 55
2.1.1.1 Key data from secondary sources 57
2.1.2 PRIMARY DATA 57
FIGURE 2 PRIMARY SOURCES 57
2.1.2.1 Key data from primary sources 58
2.1.2.2 Key industry insights 59
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE AND DEMAND SIDE PARTICIPANTS 59
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY SIDE PARTICIPANTS,
BY COMPANY TYPE, DESIGNATION, AND REGION 60
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND SIDE PARTICIPANTS,
BY END USER, DESIGNATION, AND REGION 60
2.2 MARKET SIZE ESTIMATION 61
FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC. 62
FIGURE 7 SUPPLY SIDE ANALYSIS OF TOP COMPANIES (2021) 62
FIGURE 8 CAGR PROJECTIONS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF COMPANION ANIMAL DIAGNOSTICS MARKET (2022–2027) 64
FIGURE 9 TOP-DOWN APPROACH 64
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 66
FIGURE 10 MARKET DATA TRIANGULATION METHODOLOGY 66
2.4 MARKET SHARE ESTIMATION 66
2.5 RESEARCH ASSUMPTIONS 67
2.6 RISK ASSESSMENT 67
TABLE 2 RISK ASSESSMENT: COMPANION ANIMAL DIAGNOSTICS MARKET 67
3 EXECUTIVE SUMMARY 68
FIGURE 11 COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2022 VS. 2027 (USD MILLION) 68
FIGURE 12 COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 69
FIGURE 13 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2022 VS. 2027 (USD MILLION) 70
FIGURE 14 COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 71
FIGURE 15 GEOGRAPHIC SNAPSHOT: COMPANION ANIMAL DIAGNOSTICS MARKET 72
4 PREMIUM INSIGHTS 73
4.1 COMPANION ANIMAL DIAGNOSTICS MARKET OVERVIEW 73
FIGURE 16 GROWING COMPANION ANIMAL POPULATION TO DRIVE MARKET GROWTH 73
4.2 REGIONAL MIX: COMPANION ANIMAL DIAGNOSTICS MARKET 74
FIGURE 17 ASIA PACIFIC TO REGISTER CAGR OF 10.1% DURING FORECAST PERIOD 74
4.3 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY TECHNOLOGY AND COUNTRY (2021) 75
FIGURE 18 CHINA TO HOLD LARGEST SHARE OF ASIA PACIFIC COMPANION ANIMAL DIAGNOSTICS MARKET IN 2021 75
4.4 COMPANION ANIMAL DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 76
FIGURE 19 AUSTRALIA AND MEXICO TO GROW AT HIGHEST RATE DURING FORECAST PERIOD 76
4.5 COMPANION ANIMAL DIAGNOSTICS MARKET: DEVELOPED VS. DEVELOPING MARKETS 77
FIGURE 20 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATE 77
5 MARKET OVERVIEW 78
5.1 INTRODUCTION 78
5.2 MARKET DYNAMICS 78
FIGURE 21 COMPANION ANIMAL DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 79
5.2.1 DRIVERS 79
5.2.1.1 Increasing companion animal population 79
TABLE 3 PET POPULATION, BY ANIMAL, 2014–2020 (MILLION) 80
5.2.1.2 Rising demand for pet insurance and growing animal health expenditure 80
TABLE 4 AVERAGE PREMIUMS PAID IN US, 2019 VS. 2020 81
FIGURE 22 US: PET INDUSTRY EXPENDITURE, 2010–2020 81
TABLE 5 NORTH AMERICA: PET HEALTH INSURANCE MARKET (2012–2016) (USD MILLION) 82
5.2.1.3 Growing number of veterinary practitioners and their rising income levels in developed countries 82
TABLE 6 NUMBER OF VETERINARIANS AND PARAVETERINARIANS IN DEVELOPED COUNTRIES, 2012–2018 83
5.2.2 RESTRAINTS 83
5.2.2.1 Rising pet care costs 83
5.2.3 OPPORTUNITIES 84
5.2.3.1 Increased use of PCR testing panels to rule out COVID-19 virus in animals 84
5.2.3.2 Growing demand for rapid tests and portable instruments for point-of-care diagnostic services 84
5.2.3.3 Use of advanced technologies to improve disease diagnosis accuracy in companion animals 84
5.2.4 CHALLENGES 85
5.2.4.1 Shortage of veterinary practitioners in developing countries 85
TABLE 7 NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY, 2005 VS. 2014 VS. 2018 85
5.3 INDUSTRY TRENDS 86
5.3.1 ADOPTION OF MULTIPLE TESTING PANELS 86
TABLE 8 MULTIPLE TESTING PANELS VS. SINGLE TESTING PANELS 86
5.3.2 OUTSOURCING OF VETERINARY DIAGNOSTIC TESTING SERVICES 86
5.3.3 GROWING CONSOLIDATION IN COMPANION ANIMAL DIAGNOSTICS INDUSTRY 86
TABLE 9 MAJOR ACQUISITIONS IN COMPANION ANIMAL DIAGNOSTICS INDUSTRY 87
5.4 DISEASE TRENDS 87
5.4.1 ZOONOTIC DISEASES 87
TABLE 10 COMMON ZOONOTIC DISEASES SPREAD BY COMPANION ANIMALS GLOBALLY 88
5.4.2 OBESITY AND DIABETES 89
5.5 TECHNOLOGICAL ANALYSIS 89
5.5.1 KEY TECHNOLOGY 89
5.5.1.1 Development of portable instruments for POC diagnostic services 89
TABLE 11 PONT-OF-CARE PORTABLE VETERINARY DIAGNOSTIC INSTRUMENTS 89
5.5.2 ADJACENT TECHNOLOGY 89
5.5.2.1 Development of rapid and sensitive veterinary diagnostic kits 89
5.6 PRICING ANALYSIS 90
TABLE 12 REGIONAL PRICING ANALYSIS OF VETERINARY ANALYZERS, 2019 (USD) 90
5.7 IMPACT OF COVID-19 ON COMPANION ANIMAL DIAGNOSTICS MARKET 91
TABLE 13 GLOBAL SNAPSHOT OF REPORTED CASES OF NATURALLY ACQUIRED SARS-COV-2 (COVID-19) INFECTIONS IN ANIMALS 91
FIGURE 23 MONTHLY VETERINARY PRACTICE ACTIVITY, BY REGION, JANUARY–JUNE 2020 92
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN COMPANION ANIMAL DIAGNOSTICS MARKET 93
FIGURE 24 YC–YCC SHIFT IN COMPANION ANIMAL DIAGNOSTICS MARKET 93
5.9 VALUE CHAIN ANALYSIS 93
FIGURE 25 COMPANION ANIMAL DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS 94
5.10 ECOSYSTEM MARKET MAP 94
FIGURE 26 COMPANION ANIMAL DIAGNOSTICS MARKET: ECOSYSTEM PARTICIPANTS 95
FIGURE 27 COMPANION ANIMAL DIAGNOSTICS MARKET: ECOSYSTEM MARKET MAP 96
5.11 PORTER’S FIVE FORCES ANALYSIS 97
TABLE 14 COMPANION ANIMAL DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS 97
5.11.1 THREAT OF NEW ENTRANTS 97
5.11.2 THREAT OF SUBSTITUTES 98
5.11.3 BARGAINING POWER OF SUPPLIERS 98
5.11.4 BARGAINING POWER OF BUYERS 98
5.11.5 INTENSITY OF COMPETITIVE RIVALRY 98
5.12 SUPPLY CHAIN ANALYSIS 99
FIGURE 28 COMPANION ANIMAL DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS 100
5.13 REGULATORY ANALYSIS 100
5.13.1 US 100
5.13.2 EUROPE 101
5.14 PATENT ANALYSIS 102
5.14.1 PATENT PUBLICATION TRENDS FOR COMPANION ANIMAL DIAGNOSTICS 102
FIGURE 29 PATENT PUBLICATION TRENDS (2011–APRIL 2022) 102
5.14.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 103
FIGURE 30 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR COMPANION ANIMAL DIAGNOSTICS DIAGNOSTIC PATENTS (JANUARY 2011–APRIL 2022) 103
FIGURE 31 TOP APPLICANT COUNTRIES/REGIONS FOR COMPANION ANIMAL DIAGNOSTICS PATENTS (JANUARY 2011–APRIL 2022) 104
5.15 KEY CONFERENCES & EVENTS DURING 2021-2023 104
TABLE 15 COMPANION ANIMAL DIAGNOSTICS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 104
5.16 KEY STAKEHOLDERS & BUYING CRITERIA 105
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 105
FIGURE 32 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS 105
TABLE 16 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR TOP 3 APPLICATIONS 106
5.16.2 BUYING CRITERIA 106
FIGURE 33 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 106
TABLE 17 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS 106
6 COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY 107
6.1 INTRODUCTION 108
TABLE 18 COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 108
6.1.1 IMPACT OF COVID-19 ON TECHNOLOGY TYPE 108
6.2 CLINICAL BIOCHEMISTRY 109
TABLE 19 KEY VETERINARY CLINICAL BIOCHEMISTRY PRODUCTS AVAILABLE IN MARKET 109
TABLE 20 CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 110
TABLE 21 CLINICAL BIOCHEMISTRY MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 110
6.2.1 CLINICAL CHEMISTRY ANALYSIS 111
TABLE 22 KEY CLINICAL CHEMISTRY ANALYSIS PRODUCTS AVAILABLE IN MARKET 111
TABLE 23 CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 112
TABLE 24 CLINICAL CHEMISTRY ANALYSIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 112
6.2.1.1 Reagents, clips, and cartridges 113
6.2.1.1.1 Increasing pet healthcare expenditure and rising number of screening tests performed to drive market growth 113
TABLE 25 CLINICAL CHEMISTRY REAGENTS, CLIPS, AND CARTRIDGES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 113
6.2.1.2 Analyzers 114
6.2.1.2.1 Increasing installations of clinical chemistry analyzers to drive market growth 114
TABLE 26 CLINICAL CHEMISTRY ANALYZERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 114
6.2.2 GLUCOSE MONITORING 115
TABLE 27 KEY GLUCOSE MONITORING PRODUCTS AVAILABLE IN MARKET 115
TABLE 28 GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 115
TABLE 29 GLUCOSE MONITORING MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 116
6.2.2.1 Blood glucose strips 116
6.2.2.1.1 Blood glucose strips to account for largest share of market in 2021 116
TABLE 30 BLOOD GLUCOSE STRIPS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 117
6.2.2.2 Glucose monitors 117
6.2.2.2.1 Use of glucose monitors to help in diagnostic and therapeutic decisions 117
TABLE 31 GLUCOSE MONITORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 118
6.2.2.3 Urine glucose strips 118
6.2.2.3.1 Urine glucose strips to measure glucose and ketone concentration in urine 118
TABLE 32 LIST OF KEY URINE GLUCOSE STRIPS AVAILABLE IN MARKET 119
TABLE 33 URINE GLUCOSE STRIPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 119
6.2.3 BLOOD GAS ELECTROLYTE ANALYSIS 119
TABLE 34 BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 120
TABLE 35 BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 120
6.2.3.1 Reagents, clips, and cartridges 121
6.2.3.1.1 Easy availability of animal species-specific preloaded reagent clips to support market growth 121
TABLE 36 BLOOD GAS & ELECTROLYTE REAGENT CLIPS & CARTRIDGES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 121
6.2.3.2 Blood gas & electrolyte analyzers 122
6.2.3.2.1 Blood gas and electrolyte analyzers to determine oxygen and carbon dioxide amounts in blood 122
TABLE 37 BLOOD GAS & ELECTROLYTE ANALYZERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 122
6.3 IMMUNODIAGNOSTICS 123
TABLE 38 LIST OF KEY COMPANION ANIMAL IMMUNODIAGNOSTIC PRODUCTS AVAILABLE IN MARKET 123
TABLE 39 IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 124
TABLE 40 IMMUNODIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 125
6.3.1 LATERAL FLOW ASSAYS 125
TABLE 41 LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 126
TABLE 42 LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 126
6.3.1.1 Rapid tests 127
6.3.1.1.1 Rising prevalence of infectious diseases to drive lateral flow rapid tests adoption 127
TABLE 43 LATERAL FLOW KITS: ADVANTAGES & DISADVANTAGES 127
TABLE 44 KEY PLAYERS OFFERING LATERAL TEST KITS 127
TABLE 45 LATERAL FLOW RAPID TESTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 128
6.3.1.2 Strip readers (Lateral flow readers) 129
6.3.1.2.1 Lateral flow readers to be adopted in in-house testing centers 129
TABLE 46 LATERAL FLOW STRIP READERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 130
6.3.2 ELISA TESTS 130
6.3.2.1 Elisa kits to be adopted for viral disease testing in companion animals 130
TABLE 47 ELISA: ADVANTAGES & DISADVANTAGES 131
TABLE 48 KEY PLAYERS OFFERING ELISA KITS 131
TABLE 49 ELISA TESTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 132
6.3.3 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS 132
6.3.3.1 Growing number of allergy cases in pets to drive market growth 132
TABLE 50 ALLERGEN-SPECIFIC IMMUNODIAGNOSTICS TEST KITS AVAILABLE 133
TABLE 51 ALLERGEN-SPECIFIC IMMUNODIAGNOSTIC TESTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 133
6.3.4 IMMUNOASSAY ANALYZERS 134
6.3.4.1 Large number of samples can be loaded into immunoassay analyzers to determine immunoassay tests results 134
TABLE 52 KEY PLAYERS OFFERING IMMUNOASSAY ANALYZERS 135
TABLE 53 IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 136
6.3.5 OTHER IMMUNODIAGNOSTIC PRODUCTS 136
TABLE 54 KEY PLAYERS OFFERING IMMUNOASSAY REAGENTS & CONSUMABLES 137
TABLE 55 OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 137
6.4 HEMATOLOGY 138
TABLE 56 KEY HEMATOLOGY PRODUCTS AVAILABLE 138
TABLE 57 HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 139
TABLE 58 HEMATOLOGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 139
6.4.1 CARTRIDGES 140
6.4.1.1 Hematology cartridges to measure hematocrit and hemoglobin levels in animal blood samples 140
TABLE 59 HEMATOLOGY CARTRIDGES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 140
6.4.2 ANALYZERS 141
6.4.2.1 Hematology analyzers to measure blood cell count and coagulation time of blood 141
TABLE 60 HEMATOLOGY ANALYZERS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 141
6.5 URINALYSIS 142
TABLE 61 LIST OF KEY URINALYSIS PRODUCTS AVAILABLE 142
TABLE 62 URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 143
TABLE 63 URINALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 143
6.5.1 CLIPS & CARTRIDGES/PANELS 144
6.5.1.1 Clips and cartridges/panels to measure multiple electrolytes and metabolites kidney diseases and urinary tract infections detection 144
TABLE 64 URINALYSIS CLIPS & CARTRIDGES/PANELS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 144
6.5.2 URINE ANALYZERS 145
6.5.2.1 Technological advancements to support market growth 145
TABLE 65 URINE ANALYZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 145
6.5.3 URINE TEST STRIPS 146
6.5.3.1 Urine test strips to qualitatively evaluate urine parameters 146
TABLE 66 URINE TEST STRIPS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 146
6.6 MOLECULAR DIAGNOSTICS 147
TABLE 67 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 147
TABLE 68 MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 148
6.6.1 POLYMERASE CHAIN REACTION TESTS 148
6.6.1.1 Increased laboratory usage of PCR in proteomics and genomics to support market growth 148
TABLE 69 LIST OF POLYMERASE CHAIN REACTION TESTS AVAILABLE 149
TABLE 70 PCR TESTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 150
6.6.2 MICROARRAYS 150
6.6.2.1 Growing applications of biochips in infectious diseases identification to propel market growth 150
TABLE 71 LIST OF MICROARRAYS TESTS AVAILABLE 151
TABLE 72 MICROARRAYS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 151
6.6.3 OTHER MOLECULAR DIAGNOSTIC PRODUCTS 152
TABLE 73 OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 152
6.7 OTHER COMPANION ANIMAL DIAGNOSTIC TECHNOLOGIES 153
TABLE 74 OTHER COMPANION ANIMAL DIAGNOSTIC TECHNOLOGIES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 153
7 COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION 154
7.1 INTRODUCTION 155
TABLE 75 COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 155
7.2 CLINICAL PATHOLOGY 155
7.2.1 INCREASING PET HEALTH SCREENING AND DISEASE DIAGNOSIS TO MAKE CLINICAL PATHOLOGY LARGEST APPLICATION SEGMENT 155
TABLE 76 COMPANION ANIMAL DIAGNOSTICS MARKET FOR CLINICAL PATHOLOGY,
BY COUNTRY, 2020–2027 (USD MILLION) 156
7.3 BACTERIOLOGY 156
7.3.1 RISING PREVALENCE OF ZOONOTIC DISEASES TO DRIVE MARKET GROWTH 156
TABLE 77 COMPANION ANIMAL DIAGNOSTICS MARKET FOR BACTERIOLOGY,
BY COUNTRY, 2020–2027 (USD MILLION) 157
7.4 VIROLOGY 158
7.4.1 RISING NUMBER OF VIRAL OUTBREAKS TO SUPPORT MARKET GROWTH 158
TABLE 78 COMPANION ANIMAL DIAGNOSTICS MARKET FOR VIROLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 158
7.5 PARASITOLOGY 159
7.5.1 INCREASING PREVALENCE OF PARASITIC DISEASES TO SUPPORT MARKET GROWTH 159
TABLE 79 COMPANION ANIMAL DIAGNOSTICS MARKET FOR PARASITOLOGY,
BY COUNTRY, 2020–2027 (USD MILLION) 159
7.6 OTHER APPLICATIONS 160
TABLE 80 COMPANION ANIMAL DIAGNOSTICS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 160
8 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE 161
8.1 INTRODUCTION 162
TABLE 81 COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2020–2027 (USD MILLION) 162
8.2 DOGS 163
8.2.1 RISING PET DOG POPULATION TO DRIVE MARKET GROWTH 163
TABLE 82 DOG POPULATION, BY COUNTRY, 2018–2020 (MILLION) 163
TABLE 83 COMPANION ANIMAL DIAGNOSTICS MARKET FOR DOGS, BY COUNTRY, 2020–2027 (USD MILLION) 164
8.3 CATS 164
8.3.1 GROWING RESEARCH INTO FELINE HEALTHCARE AND WELLBEING TO SUPPORT MARKET GROWTH 164
TABLE 84 CAT POPULATION, BY COUNTRY, 2018-2020 (MILLION) 165
TABLE 85 COMPANION ANIMAL DIAGNOSTICS MARKET FOR CATS, BY COUNTRY, 2020–2027 (USD MILLION) 166
8.4 HORSES 166
8.4.1 GROWING AWARENESS ABOUT EQUINE HEALTH TO DRIVE MARKET GROWTH 166
TABLE 86 COMPANION ANIMAL DIAGNOSTICS MARKET FOR HORSES, BY COUNTRY, 2020–2027 (USD MILLION) 168
8.5 OTHER COMPANION ANIMALS 168
TABLE 87 COMPANION ANIMAL DIAGNOSTICS MARKET FOR OTHER ANIMALS,
BY COUNTRY, 2020–2027 (USD MILLION) 169
9 COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER 170
9.1 INTRODUCTION 171
TABLE 88 COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION) 171
9.2 DIAGNOSTIC LABORATORIES 172
9.2.1 DIAGNOSTIC LABORATORIES TO RECEIVE LARGE SAMPLE VOLUME FOR DIAGNOSIS 172
TABLE 89 COMPANION ANIMAL DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION) 173
9.3 VETERINARY HOSPITALS & CLINICS 173
9.3.1 VETERINARY HOSPITALS & CLINICS TO BE FIRST POINTS OF CONTACT FOR PET OWNERS 173
TABLE 90 BASIC ANNUAL EXPENSES FOR CATS AND DOGS IN THE US IN
2021-2022 (USD) 174
TABLE 91 COMPANION ANIMAL DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2020–2027 (USD MILLION) 174
9.4 RESEARCH INSTITUTES & UNIVERSITIES 175
9.4.1 INCREASING INDUSTRY-ACADEMIA COLLABORATIONS TO PROPEL MARKET GROWTH 175
TABLE 92 COMPANION ANIMAL DIAGNOSTICS MARKET FOR RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY, 2020–2027 (USD MILLION) 175
9.5 HOME-CARE SETTINGS 176
9.5.1 IMPROVED CARE AND COST CONTROL TO DRIVE POC DIAGNOSTICS ADOPTION IN HOME CARE SETTINGS 176
TABLE 93 COMPANION ANIMAL DIAGNOSTICS MARKET FOR HOME-CARE SETTINGS,
BY COUNTRY, 2020–2027 (USD MILLION) 177
10 COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION 178
10.1 INTRODUCTION 179
TABLE 94 COMPANION ANIMAL DIAGNOSTICS MARKET, BY REGION,
2020–2027 (USD MILLION) 179
10.2 NORTH AMERICA 179
FIGURE 34 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET SNAPSHOT 180
TABLE 95 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 181
TABLE 96 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2020–2027 (USD MILLION) 181
TABLE 97 NORTH AMERICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 182
TABLE 98 NORTH AMERICA: LATERAL FLOW ASSAY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 182
TABLE 99 NORTH AMERICA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 182
TABLE 100 NORTH AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 183
TABLE 101 NORTH AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 183
TABLE 102 NORTH AMERICA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 183
TABLE 103 NORTH AMERICA: HEMATOLOGY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 184
TABLE 104 NORTH AMERICA: URINALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 184
TABLE 105 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 184
TABLE 106 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2020–2027 (USD MILLION) 185
TABLE 107 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 185
TABLE 108 NORTH AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY END USER, 2020–2027 (USD MILLION) 186
10.2.1 US 186
10.2.1.1 US to dominate companion animal diagnostics market in
North America 186
TABLE 109 US: PRIVATE CLINICAL PRACTICES FOR COMPANION ANIMAL,
2016 VS. 2020 186
FIGURE 35 US: EXPENDITURE ON VET VISITS 187
TABLE 110 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 187
TABLE 111 US: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 188
TABLE 112 US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 188
TABLE 113 US: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 188
TABLE 114 US: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 189
TABLE 115 US: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 189
TABLE 116 US: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 189
TABLE 117 US: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 190
TABLE 118 US: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 190
TABLE 119 US: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 190
TABLE 120 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2020–2027 (USD MILLION) 191
TABLE 121 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 191
TABLE 122 US: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION) 192
10.2.2 CANADA 192
10.2.2.1 Awareness of pet health to propel market growth 192
TABLE 123 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 193
TABLE 124 CANADA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 193
TABLE 125 CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 194
TABLE 126 CANADA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 194
TABLE 127 CANADA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 194
TABLE 128 CANADA: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 195
TABLE 129 CANADA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 195
TABLE 130 CANADA: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 195
TABLE 131 CANADA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 196
TABLE 132 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 196
TABLE 133 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 196
TABLE 134 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 197
TABLE 135 CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 197
10.3 EUROPE 198
FIGURE 36 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET SNAPSHOT 199
TABLE 136 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 200
TABLE 137 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 200
TABLE 138 EUROPE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 201
TABLE 139 EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 201
TABLE 140 EUROPE: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 201
TABLE 141 EUROPE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 202
TABLE 142 EUROPE: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 202
TABLE 143 EUROPE: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 202
TABLE 144 EUROPE: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 203
TABLE 145 EUROPE: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 203
TABLE 146 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 203
TABLE 147 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 204
TABLE 148 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 204
TABLE 149 EUROPE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 205
10.3.1 GERMANY 205
10.3.1.1 Germany to dominate European companion animal diagnostics market 205
TABLE 150 GERMANY: PET POPULATION (CATS AND DOGS), 2017 VS. 2020 (MILLION) 205
TABLE 151 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 206
TABLE 152 GERMANY: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 206
TABLE 153 GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 207
TABLE 154 GERMANY: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 207
TABLE 155 GERMANY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 207
TABLE 156 GERMANY: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 208
TABLE 157 GERMANY: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 208
TABLE 158 GERMANY: HEMATOLOGY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 208
TABLE 159 GERMANY: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 209
TABLE 160 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 209
TABLE 161 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 209
TABLE 162 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 210
TABLE 163 GERMANY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 210
10.3.2 UK 210
10.3.2.1 Stable increase in pet ownership and preventive measures against animal diseases to drive market growth 210
TABLE 164 UK: PET POPULATION (CATS AND DOGS), 2017 TO 2020 (MILLION) 211
TABLE 165 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 211
TABLE 166 UK: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 212
TABLE 167 UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 212
TABLE 168 UK: CLINICAL BIOCHEMISTRY MARKET, BY TYPE, 2020–2027 (USD MILLION) 212
TABLE 169 UK: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 213
TABLE 170 UK: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 213
TABLE 171 UK: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 213
TABLE 172 UK: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 214
TABLE 173 UK: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 214
TABLE 174 UK: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 214
TABLE 175 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2020–2027 (USD MILLION) 215
TABLE 176 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 215
TABLE 177 UK: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION) 216
10.3.3 FRANCE 216
10.3.3.1 Technological expertise and innovations to attract market players 216
TABLE 178 FRANCE: PET POPULATION (DOGS AND CATS), 2017 TO 2020 (MILLION) 216
TABLE 179 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 217
TABLE 180 FRANCE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 217
TABLE 181 FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 218
TABLE 182 FRANCE: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 218
TABLE 183 FRANCE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 218
TABLE 184 FRANCE: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 219
TABLE 185 FRANCE: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 219
TABLE 186 FRANCE: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 219
TABLE 187 FRANCE: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 220
TABLE 188 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 220
TABLE 189 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 220
TABLE 190 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 221
TABLE 191 FRANCE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION) 221
10.3.4 ITALY 221
10.3.4.1 Increased pet adoption and better availability of pet products through large-scale outlets to support market growth 221
TABLE 192 ITALY: PET POPULATION (CATS AND DOGS), 2017 TO 2020 (MILLION) 222
TABLE 193 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 222
TABLE 194 ITALY: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 222
TABLE 195 ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 223
TABLE 196 ITALY: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 223
TABLE 197 ITALY: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 223
TABLE 198 ITALY: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 224
TABLE 199 ITALY: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 224
TABLE 200 ITALY: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 224
TABLE 201 ITALY: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 225
TABLE 202 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 225
TABLE 203 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2020–2027 (USD MILLION) 225
TABLE 204 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 226
TABLE 205 ITALY: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION) 226
10.3.5 SPAIN 226
10.3.5.1 Rising animal health expenditure and growing number of veterinary facilities to drive market growth 226
TABLE 206 SPAIN: PET POPULATION (DOGS AND CATS), 2017 TO 2020 (MILLION) 227
TABLE 207 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 227
TABLE 208 SPAIN: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 228
TABLE 209 SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 228
TABLE 210 SPAIN: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 228
TABLE 211 SPAIN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 229
TABLE 212 SPAIN: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 229
TABLE 213 SPAIN: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 229
TABLE 214 SPAIN: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 230
TABLE 215 SPAIN: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 230
TABLE 216 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 230
TABLE 217 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 231
TABLE 218 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 231
TABLE 219 SPAIN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION) 232
10.3.6 BENELUX 232
10.3.6.1 Increasing pet population in Benelux to drive market growth 232
TABLE 220 BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 233
TABLE 221 BENELUX: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 233
TABLE 222 BENELUX: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 234
TABLE 223 BENELUX: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 234
TABLE 224 BENELUX: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 234
TABLE 225 BENELUX: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 235
TABLE 226 BENELUX: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 235
TABLE 227 BENELUX: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 235
TABLE 228 BENELUX: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 236
TABLE 229 BENELUX: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 236
TABLE 230 BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 237
TABLE 231 BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 237
TABLE 232 BENELUX: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 238
10.3.7 REST OF EUROPE 238
TABLE 233 ROE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY,
2020–2027 (USD MILLION) 239
TABLE 234 ROE: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 239
TABLE 235 ROE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 240
TABLE 236 ROE: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 240
TABLE 237 ROE: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 240
TABLE 238 ROE: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 241
TABLE 239 ROE: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 241
TABLE 240 ROE: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 241
TABLE 241 ROE: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 242
TABLE 242 ROE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 242
TABLE 243 ROE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE,
2020–2027 (USD MILLION) 242
TABLE 244 ROE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 243
TABLE 245 ROE: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION) 243"
"10.4 ASIA PACIFIC 244
FIGURE 37 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET SNAPSHOT 245
TABLE 246 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 246
TABLE 247 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2020–2027 (USD MILLION) 246
TABLE 248 ASIA PACIFIC: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 247
TABLE 249 ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 247
TABLE 250 ASIA PACIFIC: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 247
TABLE 251 ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 248
TABLE 252 ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 248
TABLE 253 ASIA PACIFIC: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 248
TABLE 254 ASIA PACIFIC: HEMATOLOGY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 249
TABLE 255 ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 249
TABLE 256 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 249
TABLE 257 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2020–2027 (USD MILLION) 250
TABLE 258 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 250
TABLE 259 ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 251
10.4.1 CHINA 251
10.4.1.1 China to dominate Asia Pacific companion animal diagnostics market 251
TABLE 260 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 252
TABLE 261 CHINA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 252
TABLE 262 CHINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 253
TABLE 263 CHINA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 253
TABLE 264 CHINA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 253
TABLE 265 CHINA: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 254
TABLE 266 CHINA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 254
TABLE 267 CHINA: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 254
TABLE 268 CHINA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 255
TABLE 269 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 255
TABLE 270 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 255
TABLE 271 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 256
TABLE 272 CHINA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION) 256
10.4.2 JAPAN 257
10.4.2.1 Rising demand for imported pet breeds to drive market growth 257
TABLE 273 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 257
TABLE 274 JAPAN: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 258
TABLE 275 JAPAN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 258
TABLE 276 JAPAN: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 258
TABLE 277 JAPAN: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 259
TABLE 278 JAPAN: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 259
TABLE 279 JAPAN: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 259
TABLE 280 JAPAN: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 260
TABLE 281 JAPAN: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 260
TABLE 282 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 260
TABLE 283 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 261
TABLE 284 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 261
TABLE 285 JAPAN: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION) 262
10.4.3 INDIA 262
10.4.3.1 Untapped market with large growth potential in companion animal diagnostics to support segment growth 262
TABLE 286 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 263
TABLE 287 INDIA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 263
TABLE 288 INDIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 264
TABLE 289 INDIA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 264
TABLE 290 INDIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 264
TABLE 291 INDIA: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 265
TABLE 292 INDIA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 265
TABLE 293 INDIA: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 265
TABLE 294 INDIA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 266
TABLE 295 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 266
TABLE 296 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 267
TABLE 297 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 267
TABLE 298 INDIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION) 268
10.4.4 AUSTRALIA 268
10.4.4.1 Rising pet insurance and pet health expenditure to drive market growth 268
TABLE 299 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 269
TABLE 300 AUSTRALIA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 269
TABLE 301 AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 270
TABLE 302 AUSTRALIA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 270
TABLE 303 AUSTRALIA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 270
TABLE 304 AUSTRALIA: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 271
TABLE 305 AUSTRALIA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 271
TABLE 306 AUSTRALIA: HEMATOLOGY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 271
TABLE 307 AUSTRALIA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 272
TABLE 308 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 272
TABLE 309 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 273
TABLE 310 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 273
TABLE 311 AUSTRALIA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 274
10.4.5 REST OF ASIA PACIFIC 274
TABLE 312 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2020–2027 (USD MILLION) 274
TABLE 313 REST OF ASIA PACIFIC: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 275
TABLE 314 REST OF ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 275
TABLE 315 REST OF ASIA PACIFIC: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 275
TABLE 316 REST OF ASIA PACIFIC: CLINICAL CHEMISTRY ANALYSIS MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 276
TABLE 317 REST OF ASIA PACIFIC: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 276
TABLE 318 REST OF ASIA PACIFIC: BLOOD GAS ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 276
TABLE 319 REST OF ASIA PACIFIC: HEMATOLOGY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 277
TABLE 320 REST OF ASIA PACIFIC: URINALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 277
TABLE 321 REST OF ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 277
TABLE 322 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2020–2027 (USD MILLION) 278
TABLE 323 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 278
TABLE 324 REST OF ASIA PACIFIC: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY END USER, 2020–2027 (USD MILLION) 279
10.5 LATIN AMERICA 279
TABLE 325 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 279
TABLE 326 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2020–2027 (USD MILLION) 280
TABLE 327 LATIN AMERICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 280
TABLE 328 LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 281
TABLE 329 LATIN AMERICA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 281
TABLE 330 LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 281
TABLE 331 LATIN AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 282
TABLE 332 LATIN AMERICA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 282
TABLE 333 LATIN AMERICA: HEMATOLOGY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 282
TABLE 334 LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 283
TABLE 335 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 283
TABLE 336 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2020–2027 (USD MILLION) 283
TABLE 337 LATIN AMERICA COMPANION ANIMAL DIAGNOSTICS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 284
TABLE 338 LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2020–2027 (USD MILLION) 284
10.5.1 BRAZIL 284
10.5.1.1 Brazil to possess third-largest pet population globally 284
TABLE 339 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 285
TABLE 340 BRAZIL: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 285
TABLE 341 BRAZIL: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 286
TABLE 342 BRAZIL: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 286
TABLE 343 BRAZIL: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 286
TABLE 344 BRAZIL: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 287
TABLE 345 BRAZIL: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 287
TABLE 346 BRAZIL: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 287
TABLE 347 BRAZIL: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 288
TABLE 348 BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 288
TABLE 349 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 288
TABLE 350 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 289
TABLE 351 BRAZIL: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION) 289
10.5.2 MEXICO 289
10.5.2.1 Mexico to hold second-highest position in Latin American pet care market 289
TABLE 352 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 290
TABLE 353 MEXICO: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 290
TABLE 354 MEXICO: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 291
TABLE 355 MEXICO: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 291
TABLE 356 MEXICO: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 291
TABLE 357 MEXICO: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 292
TABLE 358 MEXICO: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 292
TABLE 359 MEXICO: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 292
TABLE 360 MEXICO: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 293
TABLE 361 MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 293
TABLE 362 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 293
TABLE 363 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 294
TABLE 364 MEXICO: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION) 294
10.5.3 REST OF LATIN AMERICA 294
TABLE 365 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2020–2027 (USD MILLION) 295
TABLE 366 REST OF LATIN AMERICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 295
TABLE 367 REST OF LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 296
TABLE 368 REST OF LATIN AMERICA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 296
TABLE 369 REST OF LATIN AMERICA: CLINICAL CHEMISTRY ANALYSIS MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 296
TABLE 370 REST OF LATIN AMERICA: GLUCOSE MONITORING MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 297
TABLE 371 REST OF LATIN AMERICA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET,
BY PRODUCT, 2020–2027 (USD MILLION) 297
TABLE 372 REST OF LATIN AMERICA: HEMATOLOGY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 297
TABLE 373 REST OF LATIN AMERICA: URINALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 298
TABLE 374 REST OF LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 298
TABLE 375 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2020–2027 (USD MILLION) 298
TABLE 376 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 299
TABLE 377 REST OF LATIN AMERICA: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY END USER, 2020–2027 (USD MILLION) 299
10.6 MIDDLE EAST 300
10.6.1 RELUCTANCE TO SPEND ON PET HEALTH TO HINDER MARKET GROWTH 300
TABLE 378 MIDDLE EAST: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2020–2027 (USD MILLION) 300
TABLE 379 MIDDLE EAST: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 301
TABLE 380 MIDDLE EAST: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 301
TABLE 381 MIDDLE EAST: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 301
TABLE 382 MIDDLE EAST: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 302
TABLE 383 MIDDLE EAST: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 302
TABLE 384 MIDDLE EAST: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 302
TABLE 385 MIDDLE EAST: HEMATOLOGY MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 303
TABLE 386 MIDDLE EAST: URINALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 303
TABLE 387 MIDDLE EAST: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 303
TABLE 388 MIDDLE EAST: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2020–2027 (USD MILLION) 304
TABLE 389 MIDDLE EAST: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 304
TABLE 390 MIDDLE EAST: COMPANION ANIMAL DIAGNOSTICS MARKET,
BY END USER, 2020–2027 (USD MILLION) 305
10.7 AFRICA 305
10.7.1 DISEASES IN IMPORTED BREEDS TO DRIVE MARKET GROWTH 305
TABLE 391 AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 306
TABLE 392 AFRICA: IMMUNODIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 306
TABLE 393 AFRICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 307
TABLE 394 AFRICA: CLINICAL BIOCHEMISTRY MARKET, BY TYPE,
2020–2027 (USD MILLION) 307
TABLE 395 AFRICA: CLINICAL CHEMISTRY ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 307
TABLE 396 AFRICA: GLUCOSE MONITORING MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 308
TABLE 397 AFRICA: BLOOD GAS ELECTROLYTE ANALYSIS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 308
TABLE 398 AFRICA: HEMATOLOGY MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 308
TABLE 399 AFRICA: URINALYSIS MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 309
TABLE 400 AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 309
TABLE 401 AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2020–2027 (USD MILLION) 309
TABLE 402 AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 310
TABLE 403 AFRICA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER,
2020–2027 (USD MILLION) 310
11 COMPETITIVE LANDSCAPE 311
11.1 OVERVIEW 311
11.2 KEY PLAYER STRATEGIES 312
11.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 313
FIGURE 38 REVENUE ANALYSIS OF TOP PLAYERS IN COMPANION ANIMAL DIAGNOSTICS MARKET 313
11.4 MARKET SHARE ANALYSIS 314
FIGURE 39 COMPANION ANIMAL DIAGNOSTICS MARKET SHARE ANALYSIS,
BY KEY PLAYER, 2021 314
11.5 COMPANY EVALUATION QUADRANT 315
11.5.1 STARS 316
11.5.2 EMERGING LEADERS 316
11.5.3 PERVASIVE PLAYERS 316
11.5.4 PARTICIPANTS 316
FIGURE 40 COMPANION ANIMAL DIAGNOSTICS MARKET: COMPANY EVALUATION QUADRANT (2021) 317
11.6 COMPANY EVALUATION QUADRANT FOR STARTUPS 318
11.6.1 PROGRESSIVE COMPANIES 318
11.6.2 DYNAMIC COMPANIES 318
11.6.3 STARTING BLOCKS 318
11.6.4 RESPONSIVE COMPANIES 318
FIGURE 41 COMPANION ANIMAL DIAGNOSTICS MARKET: COMPANY EVALUATION QUADRANT FOR STARTUPS (2021) 319
11.7 COMPANY PRODUCT FOOTPRINT 320
TABLE 404 TECHNOLOGY FOOTPRINT OF MAJOR PLAYERS 320
TABLE 405 ANIMAL TYPE FOOTPRINT OF MAJOR PLAYERS 321
TABLE 406 END USER FOOTPRINT OF MAJOR PLAYERS 322
TABLE 407 GEOGRAPHIC FOOTPRINT OF MAJOR PLAYERS 323
11.8 COMPETITIVE SCENARIO 325
11.8.1 DEALS 325
TABLE 408 KEY DEALS, JANUARY 2019 TO MARCH 2022 325
11.8.2 PRODUCT LAUNCHES 326
11.8.3 OTHER DEVELOPMENTS 326
12 COMPANY PROFILES 327
12.1 KEY PLAYERS 327
(Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)*
12.1.1 IDEXX LABORATORIES, INC. 327
TABLE 409 IDEXX LABORATORIES, INC.: BUSINESS OVERVIEW 327
FIGURE 42 IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT 328
12.1.2 ZOETIS INC. 332
TABLE 410 ZOETIS, INC.: BUSINESS OVERVIEW 332
FIGURE 43 ZOETIS, INC.: COMPANY SNAPSHOT 333
12.1.3 HESKA CORPORATION 339
TABLE 411 HESKA CORPORATION: BUSINESS OVERVIEW 339
FIGURE 44 HESKA CORPORATION: COMPANY SNAPSHOT 340
12.1.4 THERMO FISHER SCIENTIFIC INC. 343
TABLE 412 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 343
FIGURE 45 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 344
12.1.5 BIOMÉRIEUX SA 347
TABLE 413 BIOMÉRIEUX SA: BUSINESS OVERVIEW 347
FIGURE 46 BIOMÉRIEUX SA: COMPANY SNAPSHOT 348
12.1.6 VIRBAC 350
TABLE 414 VIRBAC: BUSINESS OVERVIEW 350
FIGURE 47 VIRBAC: COMPANY SNAPSHOT 351
12.1.7 NEOGEN CORPORATION 353
TABLE 415 NEOGEN CORPORATION: BUSINESS OVERVIEW 353
FIGURE 48 NEOGEN CORPORATION: COMPANY SNAPSHOT 354
12.1.8 FUJIFILM HOLDINGS CORPORATION 356
TABLE 416 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW 356
FIGURE 49 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT 357
12.1.9 INDICAL BIOSCIENCE GMBH 359
TABLE 417 INDICAL BIOSCIENCE GMBH: BUSINESS OVERVIEW 359
12.1.10 IDVET 360
TABLE 418 IDVET: BUSINESS OVERVIEW 360
12.1.11 RANDOX LABORATORIES, LTD. 362
TABLE 419 RANDOX LABORATORIES, LTD.: BUSINESS OVERVIEW 362
12.1.12 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD. 364
TABLE 420 SHENZHEN MINDRAY ANIMAL MEDICAL TECHNOLOGY CO., LTD.:
BUSINESS OVERVIEW 364
12.1.13 BIONOTE, INC. 365
TABLE 421 BIONOTE, INC.: BUSINESS OVERVIEW 365
12.2 OTHER PLAYERS 368
12.2.1 SKYLA CORPORATION 368
TABLE 422 SKYLA CORPORATION: BUSINESS OVERVIEW 368
12.2.2 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG 369
TABLE 423 EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG.: BUSINESS OVERVIEW 369
12.2.3 URIT MEDICAL ELECTRONIC CO., LTD. 370
TABLE 424 URIT MEDICAL ELECTRONICS CO., LTD.: BUSINESS OVERVIEW 370
12.2.4 EUROLYSER DIAGNOSTICA GMBH 371
TABLE 425 EUROLYSER DIAGNOSTICA GMBH: BUSINESS OVERVIEW 371
12.2.5 NOVA BIOMEDICAL 372
TABLE 426 NOVA BIOMEDICAL: BUSINESS OVERVIEW 372
12.2.6 FASSISI GMBH 373
TABLE 427 FASSISI GMBH: BUSINESS OVERVIEW 373
12.2.7 SWISSAVANS AG 374
TABLE 428 SWISSAVANS AG: BUSINESS OVERVIEW 374
12.2.8 ALVEDIA 376
TABLE 429 ALVEDIA: BUSINESS OVERVIEW 376
12.2.9 MEGACOR VETERINARY DIAGNOSTICS 378
TABLE 430 MEGACOR VETERINARY DIAGNOSTICS: BUSINESS OVERVIEW 378
12.2.10 BIOPANDA REAGENTS LTD 379
TABLE 431 BIOPANDA REAGENTS LTD: BUSINESS OVERVIEW 379
12.2.11 ANIPOC LTD 380
TABLE 432 ANIPOC LTD: BUSINESS OVERVIEW 380
12.2.12 RING BIOTECHNOLOGY CO LTD. 381
TABLE 433 RING BIOTECHNOLOGY CO LTD.: BUSINESS OVERVIEW 381
*Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.
13 APPENDIX 382
13.1 DISCUSSION GUIDE 382
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 388
13.3 AVAILABLE CUSTOMIZATIONS 390
13.4 RELATED REPORTS 391
13.5 AUTHOR DETAILS 392"
US $
Euro €
GBP £
